Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / QIAGEN GmbH

Approvalsdevice cleared24 Sept 2026

QIAGEN GmbH

24 Sept 2026: Device cleared · QIAstat-Dx BCID GN Plus AMR Panel. Recorded in the openFDA device 510(k) data.

View the source record

Decided
24 Sept 2026
Device
QIAstat-Dx BCID GN Plus AMR Panel
Specialty
Microbiology
Country
Germany
Location
Hilden
Clearance type
Traditional
510(k) number
K262168
Submitted
2026-06-26
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at QIAGEN GmbH

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in Microbiology

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.